دورية أكاديمية

Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study

التفاصيل البيبلوغرافية
العنوان: Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
المؤلفون: Pennington, BeckyAff1, Alshreef, Abualbishr, Flight, Laura, Metry, Andrew, Poku, Edith, Hykin, Philip, Sivaprasad, Sobha, Prevost, A. Toby, Vasconcelos, Joana C., Murphy, Caroline, Kelly, Joanna, Yang, Yit, Lotery, Andrew, Williams, Michael, Brazier, John
المصدر: PharmacoEconomics. 39(9):1099-1099
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:11707690
11792027
DOI:10.1007/s40273-021-01057-y